
EP Edge™ Journal Watch: AVANT GUARD Trial, PFA as First-Line Therapy for Persistent AF: Half the Story
Episode 25
In this special HRS 2026 edition of EP Edge™ Journal Watch, Dr. Niraj Sharma takes a deep, clinically focused look at the AVANT GUARD trial, published in The New England Journal of Medicine, evaluating pulsed field ablation as initial therapy for treatment-naïve persistent atrial fibrillation.AVANT GUARD delivered the headline many expected: first-line PFA reduced atrial arrhythmia recurrence and AF burden compared with antiarrhythmic drug therapy, with 12-month freedom from atrial arrhythmia of 56% versus 30%. But the story underneath is more complex.This episode examines why AVANT GUARD may influence future AF guidelines while also requiring car...
Publisher
EP Edge Journal Watch: Cardiac Electrophysiology Research
Link
share.transistor.fm/s/97a3101d
Published
May 4, 2026
Duration
24 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Niraj Sharma MD FACC FHRS: Cardiac Electrophysiology & Cardiology
EP Edge Journal Watch: Cardiac Electrophysiology Research
@epedgejournalwatchcardiacele
#avantguardtrial #linetherapy #persistentaf #lifesciences #medicine
